News & Blog

Latest from the Blog

  1. May 7, 2021

    Innovating Brain Tumor Clinical Trials: Lessons Learned During the COVID-19 Experience

    The global COVID-19 pandemic disrupted nearly every facet of life in 2020, and brain cancer research, particularly clinical trials, was not spared from its impacts. As is often the case, though, with disruption comes the opportunity to innovate. Convening key stakeholders across the brain tumor community, the National Brain Tumor Society (NBTS) has taken stock […]

    Read more | 
  2. April 8, 2021

    NBTS Brain Tumor Clinical Trials Report: Q1 2021

    It can be hard to keep track of new clinical trial opportunities opening across the United States, especially during the current public health crisis created by the coronavirus (COVID-19). However, there are many clinical trials still actively enrolling patients, and this report provides a summary of the studies that have recently opened or started for […]

    Read more | 
  3. April 2, 2021

    Remembering Jeff Kolodin

    It is with deep sadness that we share news of the passing of Jeff Kolodin, former chair of the National Brain Tumor Society (NBTS) Board of Directors, due to the effects of COVID. His commitment to the brain tumor community, magnetic personality, and unstoppable perseverance have been an inspiration to patients, caregivers, researchers, corporate partners, […]

    Read more | 
    Tags:
Share